Precision Health Collaborative Steering Committee
The North Carolina Precision Health Collaborative Steering Committee guides the development of this sector for the state. Learn about the organizations and individuals involved below.
-
North Carolina Biotechnology Center
NCBiotech has identified precision health as a key strategic sector for North Carolina economic development.
Mary Beth Thomas, Ph.D. - Senior Vice President, Science and Business Development
Sara Imhof, Ph.D. - Vice President, Focused Initiative Team -
Atrium Health / Levine Cancer Institute
Atrium Health (formerly Carolinas HealthCare System) promotes research that positively impacts community health and healthcare disparities. They strive to reduce health disparities, enhance access to primary care, and improve the quality of healthcare services. Research is designed to be translational and rapidly disseminated into practice.
Jai Patel, Pharm.D., BCOP - Chief, Pharmacology Research
Sarah, Morris, Pharm.D. - Clinical Pharmacogenomic Specialist
Grace Nguyen, Pharm.D. - Clinical Pharmacogenomic Specialist -
Blue Cross Blue Shield of North Carolina
BCBS is committed to precision health as a platform for improving patient care and the effectiveness, including the cost effectiveness, in healthcare delivery and utilization.
Larry Wu, M.D. - Medical Director
-
Cone Health
Cone Health Precision Health uses personalized medicine to identify and determine potential genetic causes for symptoms.
Chad Haldeman-Englert, M.D. - Medical Director
-
Digital Health Impact + Transformation (DHIT)
DHIT is a social purpose venture dedicated to driving healthcare transformation through their digital health impact platform. They connect people and emerging technologies, matching ecosystem needs with validated solutions through demand-driven collaboration and innovation.
Michael Levy, MBA - President
-
Duke Margolis Center for Health Policy
Marianne Hamilton Lopez, Ph.D., MPA - Research Director
-
Duke University
Duke has conducted extensive research in precision health and has provided a national leadership role in the implementation and adoption of precision health in patient care.
Svati Shah, M.D., MHS - Director, Center for Precision Health
Deepak Voora, M.D. - Associate Professor of Medicine
Lisa Bendz, Pharm.D. - Medication Policy Clinical Pharmacist & Clinical Pharmacist Practitioner
Meghan Mac Neal, M.S., M.P.H. - Clinical Research Genetic Counselor -
Durham VA Medical Center
The Durham Veterans Affairs Medical Center has been improving the health of the men and women who have so proudly served our nation. Services are available to more than 200,000 Veterans living in a 27-county area of central and eastern North Carolina.
Deepak Voora, Executive Director - VA National Pharmacogenomics Program
Jill Bates, Deputy Executive Director - VA National Pharmacogenomics Program -
GeriatRx Inc.
GeriatRx is a pharmacist-led consulting service that focuses not only on chronic medication management, but also identifies that there is a lack of support for parents who are caregivers or for the elderly who need help in maneuvering a very difficult health care landscape.
DeLon Canterbury, Pharm.D. - Chief Executive Officer -
JMP Life Sciences, SAS Institute
JMP is a division of SAS that produces interactive statistical discovery software. JMP Genomics provides exceptional tools for genetics research, pharmacogenomics, expression analysis, and many other precision health applications.
Wenjun Bao, Ph.D. - Chief Scientist and R&D Manager
-
North Carolina State University
North Carolina State University has been at the forefront of developing quantitative methods to support the practice of personalized medicine by leveraging and integrating their diverse expertise to pursue new methodological innovation for discovery of precision medicine strategies.
Fred Wright, Ph.D. - Professor and Director of the Bioinformatics Research Center
Yi-Hui Zhou, Ph.D. - Associate Professor and Associate Director, Bioinformatics Research Center -
Pappas Ventures
Pappas Ventures, like NCBiotech, sees significant market and investment potential in precision health research and companies.
Peter Young, MBA - Executive-in-Residence
-
Renaissance Computing Institute
Renaissance Computing Institute (RENCI) develops and deploys advanced technologies to enable research discoveries and practical innovations. RENCI strives to be a leader in data science and an essential catalyst for data driven discoveries leading to better health.
Rebecca Boyles, MSPH - Deputy Director
-
RTI International
RTI has a number of initiatives in precision health, including studies on the environmental impact on population health, data analytics and the development of mobile health applications to support patient engagement.
Olivia Dong, Ph.D., Senior Research Health Economist
-
University of North Carolina - Chapel Hill
The University of North Carolina at Chapel Hill has a rich history of precision health with its clinical and research functions. Also, UNC’s Renaissance Computing Institute has developed expertise in health informatics and data science, which underlie precision health discoveries. The Institute also leads in developing mechanisms for data sharing across institutions.
Jonathan Berg, M.D., Ph.D.- Bryson Distinguished Professor, Genetics and Medicine
Don Hobart, J.D. - Associate Vice Chancellor for Research
Amber Cipriani - Pharm.D. - Precision Medicine Pharmacy Coordinator
Megan Roberts, Ph.D. - Director of Implementation Science in Precision Health & Society
Melissa Haendel, Ph.D. - Director of Precision Health & Translational Informatics -
University of North Carolina - Greensboro
The Precision Health & Wellness Institute (PHWI) is a leading-edge collaboration between Cone Health and the University of North Carolina at Greensboro. It adopts a precision health model, tailoring care to individuals based on genetics, lifestyle, and environment, supported by multidisciplinary teams from genetics, nutrition, physical therapy, and counseling.
Rachel Mills, Ph.D. - Assistant Professor, Genetic Counseling
-
Wake Forest University
The Center for Precision Medicine at Wake Forest School of Medicine develops and supports innovative, collaborative, and multidisciplinary research into the causes of common human disorders to improve long-term health outcomes for patients.
Michael Olivier, Ph.D. - Director, Center for Precision Medicine and Professor, Department of Internal Medicine, Section of Molecular Medicine
Lori Orlando, M.D., MHA - Professor of Medicine -
WakeMed Health and Hospitals
Casey Granack, MHA - Manager, Innovations
David Kirk, M.D. - Chief Clinical Integration Officer
For questions or more information, contact:
Sara Imhof, Ph.D.
Vice President, Focused Initiatives Team
Focused Initiatives
919-549-8842
|
[email protected]